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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S56returned to control levels when synovial ﬁbroblasts were co-incubated
with PGF2a inhibitor AL8810 whereas inhibition of TGFb signaling with
SB505124 had no effect. aSMA gene expression and collagen production
were unaffected by inhibition of TGFb or PGF2a signaling. The increased
synovial ﬁbroblast migration in response to FCM could not be counter-
acted by SB505124, but was partially counteracted by AL8810. Synovial
ﬁbroblast proliferation in response to FCM was unaffected either by
SB505142 or AL8810.
Conclusions: These results indicate that infrapatellar fat can contribute for
the development of synovial ﬁbrosis by increasing collagen production,
PLOD2 gene expression, cell proliferation and cell migration; all charac-
teristics of a ﬁbrotic process. Based on our results, not TGFb but the more
recently discovered pro-ﬁbrotic factor PGF2a seems partly responsible for
the observed effects.
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EFFECT OF CHONDROITIN SULFATE ON THE FACTORS INVOLVED IN
SYNOVIAL INFLAMMATION
J. Martel-Pelletier, Sr. 1, F. Mineau, Sr. 1, E. Montell, Sr. 2, J. Vergés, Sr. 2,
J.-P. Pelletier, Jr. 1. 1Osteoarthritis Res. Unit, Univ. of Montreal Hosp. Res. Ctr.
(CRCHUM), Notre-Dame Hosp., Montreal, QC, Canada; 2 Pharmacological Res.
Unit, Scientiﬁc Med. Dept., Bioibérica, Barcelona, Spain
Purpose: Chondroitin sulfate (CS), an interesting candidate for the thera-
peutic treatment of osteoarthritis (OA), has been shown in clinical trials to
reduce swelling and effusion in knee OA. We thus aimed to further
investigate the effect of CS alone or in combination with glucosamine
sulfate (GS), an anti-COX-2 (celecoxib), or acetaminophen on some syno-
vial membrane anti-angiogenic and inﬂammatory factors.
Methods: Treatment with CS (200 mg/ml; CSbBio-Active, Bioibérica,
Spain), GS (5 mM), celecoxib or acetaminophen alone, and CS in combi-
nation with the other mentioned products was investigated on human OA
synovial ﬁbroblasts in the presence or absence of IL-1b at 10 and 100 ng/
ml. To determine whether CS has an additional effect with celecoxib or
acetaminophen, preliminary experiments were performed to ﬁnd
concentrations of these products that induced about a 50% reduction in
prostaglandin E2 production under IL-1b at 100 ng/ml. A concentration of
10 nM was found for celecoxib and 25 mM for acetaminophen. The
expression levels (real time PCR) and/or protein production of vascular
endothelial growth inhibitor (VEGI), thrombospondin-1 (TSP-1), hyalur-
onic acid (HA), secreted phospholipase 2 (sPLA2), and cytosolic phospho-
lipase 2 (cPLA2) were determined using speciﬁc primers (expression) and
ELISAs (protein).
Results: On the anti-angiogenic factors VEGI and TSP-1, IL-1b dose-
dependently decreased their levels. On cells under basal conditions or
treated with IL-1b, CS signiﬁcantly induced the levels of VEGI expression
and TSP-1 production. All the other products tested (GS, celecoxib, and
acetaminophen) alone had no effect or decreased these anti-angiogenic
factors, but in conjunctionwith CS their levels were signiﬁcantly increased.
HA productionwas slightly but signiﬁcantly increased by IL-1b at 10 ng/ml
and a heightened induction was found at 100 ng/ml. CS signiﬁcantly
increased HA under basal conditions and in the presence of IL-1b at 10 ng/
ml. GS had no effect and celecoxib and acetaminophen signiﬁcantly
decreased it. Concomitant incubation of CS with GS, celecoxib, or acet-
aminophen signiﬁcantly increased HA production. Interestingly, sPLA2,
which is considered an anti-inﬂammatory (resolving) factor, demonstrated
a signiﬁcant decrease under IL-1b. Incubation with CS alone and in
conjunction with celecoxib or acetaminophen signiﬁcantly increased its
level. The inﬂammatory factor cPLA2 showed signiﬁcantly decreased
expression levels by CS, GS, and the combination of CS and GS. IL-1b
markedly and signiﬁcantly increased it at both concentrations and under
IL-1b, CS alone had no effect, but in combination with GS, its level was
signiﬁcantly reduced.
Conclusions: The anti-inﬂammatory effect of CS appears to occur through
a number of mechanisms including the inhibition of the anti-angiogenic
factors TSP-1 and VEGI as well as sPLA2, a factor associated with an anti-
inﬂammatory effect, and through increasing HA production and
decreasing cPLA2. Importantly, these effects of CS occurred in the presence
of other products, even though those products alone had no or a reverse
effect.97
EXPRESSION OF SPECIFIC PATHWAYS IN THE INFLAMED SYNOVIAL
MEMBRANE OF OSTEOARTHRITIS PATIENT: IDENTIFICATION OF NEW
POTENTIAL KEY INTERMEDIATES
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Y. Henrotin 1. 1Bone and Cartilage Res. Unit, Univ. of Liège, Liège, Belgium;
2Orthopaedic Dept., Cliniques Univ. Saint Luc, Brussels, Belgium; 3GIGA
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Purpose: Synovitis is a key factor in osteoarthritis (OA) pathophysiology,
contributing to both patient symptoms and disease progression. In this
study, using an original methodology comparing normal/reactive (N/R)
and inﬂammatory (I) synovial membranes zones, we investigated the gene
expression proﬁles of synovial cells from these areas and identiﬁed
differentially regulated pathways.
Methods: Synovial cells (SC) were isolated from OA synovial specimens
obtained from 12 patients undergoing knee replacement. The inﬂamma-
tory status of the synovial membrane was characterized by the surgeon
according to macroscopic criteria including the synovial vascularization,
the villi formation and the hypertrophic aspect of the tissue. At the surgery
time, the synovial membrane was dissected and biopsies from N/R and I
areas cultured separately for a period of 7 days. Total RNA was extracted
using the RNeasy Mini Kit. RNA purity and quality were evaluated using
the Experion RNA StdSens Analysis kit (Bio-rad Laboratories). Gene
expression proﬁling between N/R and I areas was performed using Illu-
mina's multi-sample format Human HT-12 BeadChip (Illumina Inc.).
Differential analysis was performed with the BRB array tools software.
Class Comparison test between N/R and I areas was based on paired t-test
where N/R and I were paired for each patient. The biological relevance of
up- and down-regulated genes was analyses with Ingenuity Pathways
Analysis (Ingenuity Systems). Western blot was performed to conﬁrm
certain intermediate expression.
Results: From among 47000 probes, 17500 were ﬁltered out. Probes with
a p-value below than 0.005 were chosen and classiﬁed as up- or down-
regulated ones. By this way, 896 differentially expressed genes between N/
R and I zoneswere identiﬁed. Among these, 576 geneswere upregulated (I/
NR > 1.5) and 320 downregulated (I/NR < 0.75). With Ingenuity Pathways
Analysis, a signiﬁcant number of the top ranking differentially expressed
genes were identiﬁed as inﬂammatory, Wnt and angiogenic pathways.
Interleukin (IL)-6 and -8, chemokines (CXCL1, CXCL2, CXCL5, CXCL6,
CXCL16) and arachidonate 5-lipoxygenase (ALOX5) were identiﬁed as the
most upregulated in I zones in the inﬂammatory pathway. Interestingly,
the alarmin S100A9 was found strongly upregulated in this pathway.
Wnt5A and LRP (Low density lipoprotein receptor-related protein) 5 were
upregulated whereas FZD (Frizzled homolog) 2 and DKK (dickkopf
homolog) 3 were downregulated in the Wnt signaling pathway. Finally,
stanniocalcin (STC)-1, an intermediate in angiogenesis was identiﬁed as
the most upregulated gene in I zones compared to N/R zones. This
difference of expression was conﬁrmed at the protein level.
Conclusions: Using a unique culture system, this study is the ﬁrst to
identify different expression pattern between two areas of synovial
membrane from the same OA patient. These differences concern several
key pathways involved in OA pathogenesis, i.e. inﬂammation, Wnt and
angiogenesis. This analysis also provided interesting information
regarding new potent intermediates as S100A9 and STC-1. They could be
potential targets for chondroitin sulfate, one of the most used molecules in
the management of OA. New experiments are being perfomed at the
moment to elucidate the potential effect of this molecule on these speciﬁc
differentially expressed genes in the same culture system.
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SYNOVIAL INFLAMMATION CORRELATES WITH MENISCAL PATHOLOGY
IN A COHORT OF PATIENTS UNDERGOING ACL RECONSTRUCTION FOR
TRAUMATIC ACL RUPTURE
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